News
BIOQ
77.00
NaN%
--
Weekly Report: what happened at BIOQ last week (0422-0426)?
Weekly Report · 6d ago
Press Release: BIOQUAL Presents Unaudited Financial Results for Third Quarter of Fiscal Year 2024
BIOQUAL Presents Unaudited Financial Results for Third Quarter of Fiscal Year 2024. The company's results are forward-looking and subject to risks and uncertainties. BIOQUAL's revenue for the third quarter of fiscal year 2024 was $46.2 million. The Company's animal models are used in scientific research.
Dow Jones · 04/22 16:02
Weekly Report: what happened at BIOQ last week (0415-0419)?
Weekly Report · 04/22 12:28
Weekly Report: what happened at BIOQ last week (0408-0412)?
Weekly Report · 04/15 12:18
Weekly Report: what happened at BIOQ last week (0401-0405)?
Weekly Report · 04/08 12:23
Weekly Report: what happened at BIOQ last week (0325-0329)?
Weekly Report · 04/01 12:19
Weekly Report: what happened at BIOQ last week (0318-0322)?
Weekly Report · 03/25 12:23
Weekly Report: what happened at BIOQ last week (0311-0315)?
Weekly Report · 03/18 12:21
Weekly Report: what happened at BIOQ last week (0304-0308)?
Weekly Report · 03/11 12:16
Weekly Report: what happened at BIOQ last week (0226-0301)?
Weekly Report · 03/04 12:20
Weekly Report: what happened at BIOQ last week (0219-0223)?
Weekly Report · 02/26 12:41
Weekly Report: what happened at BIOQ last week (0212-0216)?
Weekly Report · 02/19 12:43
Weekly Report: what happened at BIOQ last week (0205-0209)?
Weekly Report · 02/12 12:27
Weekly Report: what happened at BIOQ last week (0129-0202)?
Weekly Report · 02/05 12:40
Weekly Report: what happened at BIOQ last week (0122-0126)?
Weekly Report · 01/29 12:22
BIOQUAL GAAP EPS of $0.54, revenue of $15.87M
Seeking Alpha · 01/24 06:42
Press Release: Bioqual Presents Unaudited Financial Results for Second Quarter of Fiscal Year 2024
Bioqual Presents Unaudited Financial Results for Second Quarter of Fiscal Year 2024. The Company's results are forward-looking and subject to risks and uncertainties. The company's revenue for the second quarter of fiscal year 2024 was $31.2 million. The firm's animal models are used in scientific research.
Dow Jones · 01/23 17:25
Weekly Report: what happened at BIOQ last week (0115-0119)?
Weekly Report · 01/22 12:29
Weekly Report: what happened at BIOQ last week (0108-0112)?
Weekly Report · 01/15 12:23
Weekly Report: what happened at BIOQ last week (0101-0105)?
Weekly Report · 01/08 12:29
More
Webull provides a variety of real-time BIOQ stock news. You can receive the latest news about Bioqual through multiple platforms. This information may help you make smarter investment decisions.
About BIOQ
Bioqual, Inc. is a provider of research, development, consulting and testing/assay services to commercial clients and Government laboratories. The Company supports the National Institutes of Health by providing research services in the research areas of cancer, acquired immune deficiency syndrome (AIDS), hepatitis, influenza, immunology, transgenics, contraception, breeding and development of genetically defined animals, and neurobiology and behavior. The Company's research contracts consist of cancer virus studies, congenic animal development and monoclonal antibody research. The Company's research services include primate biology and medicine, small laboratory animal sciences, infectious disease research, in vitro laboratory services, environmental enrichment and behavior, good laboratory practice (GLP) studies, and partnerships for contracts and grants. The Company holds government contracts, which utilize the non-human primate model to study assorted human diseases.